<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Nguyen H</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Previous studies verify the formation of enzymatically post-translationally modified (PTM) self-peptides and their preferred recognition by T cells in subjects with type 1 diabetes (T1D). However, questions remain about the relative prevalence of T cells that recognize PTM self-peptides derived from different antigens, their functional phenotypes, and whether their presence correlates with a specific disease endotype.&lt;h4>Methods&lt;/h4>To address this question, we identified a cohort of subjects with T1D who had diverse levels of residual beta cell function. Using previously developed HLA class II tetramer reagents, we enumerated T cells that recognize PTM GAD epitopes in the context of DRB1*04:01 or PTM IA2 epitopes in the context of DQB1*03:02 (DQ8).&lt;h4>Results&lt;/h4>Cons</pubmed_abstract><journal>Frontiers in immunology</journal><pagination>1015855</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9871889</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Characterizing T cell responses to enzymatically modified beta cell neo-epitopes.</pubmed_title><pmcid>PMC9871889</pmcid><pubmed_authors>Arribas-Layton D</pubmed_authors><pubmed_authors>Chow IT</pubmed_authors><pubmed_authors>Nguyen H</pubmed_authors><pubmed_authors>Kwok WW</pubmed_authors><pubmed_authors>Speake C</pubmed_authors><pubmed_authors>Hessner MJ</pubmed_authors><pubmed_authors>Greenbaum CJ</pubmed_authors><pubmed_authors>James EA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Characterizing T cell responses to enzymatically modified beta cell neo-epitopes.</name><description>&lt;h4>Introduction&lt;/h4>Previous studies verify the formation of enzymatically post-translationally modified (PTM) self-peptides and their preferred recognition by T cells in subjects with type 1 diabetes (T1D). However, questions remain about the relative prevalence of T cells that recognize PTM self-peptides derived from different antigens, their functional phenotypes, and whether their presence correlates with a specific disease endotype.&lt;h4>Methods&lt;/h4>To address this question, we identified a cohort of subjects with T1D who had diverse levels of residual beta cell function. Using previously developed HLA class II tetramer reagents, we enumerated T cells that recognize PTM GAD epitopes in the context of DRB1*04:01 or PTM IA2 epitopes in the context of DQB1*03:02 (DQ8).&lt;h4>Results&lt;/h4>Cons</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-22T06:20:44.649Z</modification><creation>2025-04-05T21:40:19.857Z</creation></dates><accession>S-EPMC9871889</accession><cross_references><pubmed>36703975</pubmed><doi>10.3389/fimmu.2022.1015855</doi></cross_references></HashMap>